about
Tumor-Derived Cell Lines as Molecular Models of Cancer PharmacogenomicsAssessing breast cancer cell lines as tumour models by comparison of mRNA expression profiles.Laser Capture Microdissection as a Tool to Study Tumor Stroma.The expression pattern of matrix-producing tumor stroma is of prognostic importance in breast cancerC1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation.The past and future of breast cancer treatment-from the papyrus to individualised treatment approaches.Identification and prognostic value of anterior gradient protein 2 expression in breast cancer based on tissue microarray.Immune infiltrates in the breast cancer microenvironment: detection, characterization and clinical implication.C1q: A fresh look upon an old molecule.Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancer.The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis.Prognostic and functional role of subtype-specific tumor-stroma interaction in breast cancer.Tissue and plasma levels of galectins in patients with high grade serous ovarian carcinoma as new predictive biomarkersComplement Protein C1q Binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumor Growth.An integrative functional genomics framework for effective identification of novel regulatory variants in genome-phenome studies.Complement Component C1q: Historical Perspective of a Functionally Versatile, and Structurally Unusual, Serum Protein.Hyaluronan, Cancer-Associated Fibroblasts and the Tumor Microenvironment in Malignant Progression.
P2860
Q26801410-E8366598-8AB2-4B1B-80ED-26E023398FF9Q35986078-E8FE8254-9A72-477C-A34B-1DF2090CCE15Q36118789-8B2423AA-9494-44AC-8B87-A2D231886E2DQ36181412-43866CD7-FE5F-4D8D-A71A-A1D7BE6A077DQ36541076-402C349E-95E5-495F-ADD2-233C05F4494AQ38660610-9EEDE958-F380-4914-A5B9-7F30FF2318B7Q38697199-63B8F500-F079-4342-9F2B-C39F8EDD42E1Q38823649-8079C3D6-81F6-48F3-AD4E-FA4A8FDAC353Q39364237-974A0353-A160-48BD-88B7-20173838C6BBQ40058263-74687CEB-8547-4F7A-8ABF-5F84ACC7E6DDQ40357845-CD1016B1-F034-4351-B418-73383584D198Q41880628-3B1043A7-E0CB-44FD-BEBC-E070A685D20FQ42378844-DF33EF44-176C-476A-9945-48736A947F64Q47095454-6B68C473-2E67-40F1-827B-09760E9D1621Q47551019-B2507AFC-42A9-4746-982C-711A6C91E84DQ52310303-73B6A9D8-54E8-4A2E-B96A-8356C41A26A5Q55065517-33FE0DB4-3037-45F2-95E4-B77C4D1C1491
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Prognostic stromal gene signatures in breast cancer.
@ast
Prognostic stromal gene signatures in breast cancer.
@en
type
label
Prognostic stromal gene signatures in breast cancer.
@ast
Prognostic stromal gene signatures in breast cancer.
@en
prefLabel
Prognostic stromal gene signatures in breast cancer.
@ast
Prognostic stromal gene signatures in breast cancer.
@en
P2093
P2860
P1476
Prognostic stromal gene signatures in breast cancer
@en
P2093
Anders Edsjö
Christer Larsson
Sofia Winslow
P2860
P2888
P356
10.1186/S13058-015-0530-2
P577
2015-02-21T00:00:00Z
P5875
P6179
1031128667